Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine.
BACKGROUND
Accumulating evidence suggests that certain dietary polyphenols have biological effects in the small intestine that alter the pattern of glucose uptake. Their effects, however, on glucose tolerance in humans are unknown.


OBJECTIVE
The objective was to investigate whether chlorogenic acids in coffee modulate glucose uptake and gastrointestinal hormone and insulin secretion in humans.


METHODS
In a 3-way, randomized, crossover study, 9 healthy fasted volunteers consumed 25 g glucose in either 400 mL water (control) or 400 mL caffeinated or decaffeinated coffee (equivalent to 2.5 mmol chlorogenic acid/L). Blood samples were taken frequently over the following 3 h.


RESULTS
Glucose and insulin concentrations tended to be higher in the first 30 min after caffeinated coffee consumption than after consumption of decaffeinated coffee or the control (P < 0.05 for total and incremental area under the curve for glucose and insulin). Glucose-dependent insulinotropic polypeptide secretion decreased throughout the experimental period (P < 0.005), and glucagon-like peptide 1 secretion increased 0-120 min postprandially (P < 0.01) after decaffeinated coffee consumption compared with the control. Glucose and insulin profiles were consistent with the known metabolic effects of caffeine. However, the gastrointestinal hormone profiles were consistent with delayed intestinal glucose absorption.


CONCLUSIONS
Differences in plasma glucose, insulin, and gastrointestinal hormone profiles further confirm the potent biological action of caffeine and suggest that chlorogenic acid might have an antagonistic effect on glucose transport. Therefore, a novel function of some dietary phenols in humans may be to attenuate intestinal glucose absorption rates and shift the site of glucose absorption to more distal parts of the intestine.
Johnston
Kelly L
KL
Centre for Nutrition and Food Safety, School of Biomedical and Molecular Sciences, University of Surrey, Guildford, United Kingdom.
Clifford
Michael N
MN
Morgan
Linda M
LM
D000328:Adult; D019540:Area Under Curve; D001786:Blood Glucose / Q000187:drug effects*; D002110:Caffeine / Q000494:pharmacology*; D002726:Chlorogenic Acid / Q000494:pharmacology*; D003069:Coffee; D018592:Cross-Over Studies; D004032:Diet; D005260:Female; D005419:Flavonoids; D005768:Gastrointestinal Hormones / Q000378:metabolism*; D005934:Glucagon / Q000097:blood*; D052216:Glucagon-Like Peptide 1; D005947:Glucose / Q000493:pharmacokinetics*; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D010446:Peptide Fragments / Q000097:blood*; D010636:Phenols / Q000008:administration & dosage / Q000494:pharmacology*; D011108:Polymers / Q000008:administration & dosage / Q000494:pharmacology*; D059808:Polyphenols; D019518:Postprandial Period; D011498:Protein Precursors / Q000097:blood*
D001786:Blood Glucose; D003069:Coffee; D005419:Flavonoids; D005768:Gastrointestinal Hormones; D007328:Insulin; D010446:Peptide Fragments; D010636:Phenols; D011108:Polymers; D059808:Polyphenols; D011498:Protein Precursors; D002726:Chlorogenic Acid; D002110:Caffeine; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D005947:Glucose